Company or ticker...

Halozyme

Halozyme Therapeutics is a biopharmaceutical company focused on the development and commercialization of oncology therapies and drug delivery technologies.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

HALO

8.5B

5.5

25.6

5.27%

Key Facts

M. Cap

PS

PE

YTD

8.5B

5.5

25.6

5.27%

10MA

20MA

50MA

200MA

$HALO